1 / 5

Thromboembolism - Pipeline Review, H1 2015

Global Markets Direct’s, ‘Thromboembolism - Pipeline Review, H1 2015’, provides an overview of the Thromboembolism’s therapeutic pipeline. This report provides comprehensive information on the therapeutic development for Thromboembolism, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Thromboembolism and special features on late-stage and discontinued projects. Read the Complete Report @ http://www.researchbeam.com/thromboembolism-pipeline-review-h1-2015-market

Alexus
Download Presentation

Thromboembolism - Pipeline Review, H1 2015

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Thromboembolism - Pipeline Review, H1 2015 Industry Size, Share, Global Trends, Company Profiles, Demand, Insights, Analysis, Research, Report, Opportunities, and Forecast 2015 • TELEPHONE: +1 (855) 711-1555E-MAIL: sales@researchbeam.com

  2. Report overview Research Beam adds a report titled "Thromboembolism - Pipeline Review, H1 2015". The report provides an in-depth study on the Thromboembolism Industry Analysis, opportunities and factors influencing the market. Summary Global Markets Direct’s, ‘Thromboembolism - Pipeline Review, H1 2015’, provides an overview of the Thromboembolism’s therapeutic pipeline. This report provides comprehensive information on the therapeutic development for Thromboembolism, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Thromboembolism and special features on late-stage and discontinued projects. Global Markets Direct’s report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct’s proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct’s team. The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.

  3. Report overview Scope - The report provides a snapshot of the global therapeutic landscape of Thromboembolism - The report reviews key pipeline products under drug profile section which includes, product description, MoA and R&D brief, licensing and collaboration details & other developmental activities - The report reviews key players involved in the therapeutics development for Thromboembolism and enlists all their major and minor projects - The report summarizes all the dormant and discontinued pipeline projects - A review of the Thromboembolism products under development by companies and universities/research institutes based on information derived from company and industry-specific sources - Pipeline products coverage based on various stages of development ranging from pre-registration till discovery and undisclosed stages - A detailed assessment of monotherapy and combination therapy pipeline projects - Coverage of the Thromboembolism pipeline on the basis of target, MoA, route of administration and molecule type - Latest news and deals relating related to pipeline products

  4. Report overview Reasons to buy - Provides strategically significant competitor information, analysis, and insights to formulate effective R&D development strategies - Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage - Develop strategic initiatives by understanding the focus areas of leading companies - Identify and understand important and diverse types of therapeutics under development for Thromboembolism - Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline - Devise corrective measures for pipeline projects by understanding Thromboembolism pipeline depth and focus of Indication therapeutics - Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope - Modify the therapeutic portfolio by identifying discontinued projects and understanding the factors that drove them from pipeline Enquire about report @: http://www.researchbeam.com/thromboembolism-pipeline-review-h1-2015-market/enquire-about-report

  5. FOR MORE DETAILS Visit us at : http://www.researchbeam.com/thromboembolism-pipeline-review-h1-2015-market • TELEPHONE: +1 (855) 711-1555E-MAIL: sales@researchbeam.com 5933 NE Win Sivers Drive,#205, Portland, OR 97220United States Stay With Us:

More Related